NASDAQ:ACHL   Achilles Therapeutics plc
Achilles Therapeutics PLC (NASDAQ:ACHL) is another undervalued small bio cancer play like PHIO with $6 per share in cash and many upcoming catalysts and presentations. Low risk swing from here. Watch the break of the declining EMA50 on volume for a strong rally to the EMA200 that lies at 6.21 I have been accumulating.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.